A Study Investigating the Efficacy, Safety, and PK Profile of ANB020 Administered to Adult Subjects With Moderate-to-Severe AD



Status:Recruiting
Conditions:Psoriasis, Dermatology, Dermatology, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:18 - 75
Updated:3/14/2019
Start Date:May 23, 2018
End Date:September 2019
Contact:Kham Phenis
Email:ANB020-005@anaptysbio.com
Phone:858-362-6295

Use our guide to learn which trials are right for you!

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, and Pharmacokinetic Profile of ANB020 Administered to Adult Subjects With Moderate-to-Severe Atopic Dermatitis

This study is designed to evaluate the efficacy, safety, and pharmacokinetic (PK) profiles of
multiple doses of ANB020 in subjects with atopic dermatitis (AD).

This is a multi-center, randomized, double blind, placebo controlled, parallel group, dose
ranging study investigating the efficacy, safety, and pharmacokinetic profile of ANB020
administered to adult subjects with moderate-to-severe atopic dermatitis.

Inclusion Criteria:

1. Male or female subjects must be 18 to 75 years of age, at the time of signing the
informed consent.

2. Body mass index (BMI) of 18 to ≤35 kg/m2 at screening.

3. Clinically confirmed diagnosis AD.

4. Eczema Area and Severity Index (EASI) score ≥16, body surface area (BSA) involvement
≥10%, and an Investigator's Global Assessment (IGA) score (5-point scale) ≥3 at
baseline.

5. Subjects with a history of inadequate response to topical treatment, use of systemic
treatments to treat AD, and/or for whom topical treatments are otherwise medically
inadvisable.

6. Daily use of non-medicated emollient for at least 7 days prior to baseline.

Exclusion Criteria:

1. Treatment with topical corticosteroids, topical calcineurin inhibitors, or crisaborole
within 2 weeks before dosing.

2. Prior exposure to an anti-IL-33 antibody.

3. Exposure to an investigational or licensed or other anti Th2 type cytokine or cytokine
receptor antagonist within 16 weeks or 5 half-lives, whichever is longer.

4. History of prior exposure to any investigational or biologic systemic treatment within
5 half lives of the screening or is currently enrolled in another clinical study.

5. Have received systemic treatment for AD (including systemic corticosteroids,
immunosuppressants or immunomodulating drugs, or phototherapy or use of a tanning
booth) within 4 weeks before screening.

6. History of severe allergic or anaphylactic reactions to human, humanized, chimeric, or
murine monoclonal antibodies.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.
We found this trial at
33
sites
Oklahoma City, Oklahoma 73104
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Albany, Georgia 31707
?
mi
from
Albany, GA
Click here to add this to my saved trials
Albuquerque, New Mexico 87102
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Bay City, Michigan 48706
?
mi
from
Bay City, MI
Click here to add this to my saved trials
Birmingham, Alabama 35213
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Columbus, Ohio 43221
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Coppell, Texas 75019
?
mi
from
Coppell, TX
Click here to add this to my saved trials
Dallas, Texas 75231
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Edmonton, Alberta
?
mi
from
Edmonton,
Click here to add this to my saved trials
Encino, California 91436
?
mi
from
Encino, CA
Click here to add this to my saved trials
Forest Hills, New York 11375
?
mi
from
Forest Hills, NY
Click here to add this to my saved trials
Houston, Texas 77058
?
mi
from
Houston, TX
Click here to add this to my saved trials
Irvine, California 92618
?
mi
from
Irvine, CA
Click here to add this to my saved trials
Johnston, Rhode Island 02919
?
mi
from
Johnston, RI
Click here to add this to my saved trials
Little Rock, Arkansas 72211
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
Louisville, Kentucky 40202
?
mi
from
Louisville, KY
Click here to add this to my saved trials
Macon, Georgia 31217
?
mi
from
Macon, GA
Click here to add this to my saved trials
Marietta, Georgia 30060
?
mi
from
Marietta, GA
Click here to add this to my saved trials
Medford, Oregon 97504
?
mi
from
Medford, OR
Click here to add this to my saved trials
Miami, Florida 33145
?
mi
from
Miami, FL
Click here to add this to my saved trials
Miramar, Florida 33027
?
mi
from
Miramar, FL
Click here to add this to my saved trials
New York, New York 10128
?
mi
from
New York, NY
Click here to add this to my saved trials
Normal, Illinois 61761
?
mi
from
Normal, IL
Click here to add this to my saved trials
Orlando, Florida 32803
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Overland Park, Kansas 66211
?
mi
from
Overland Park, KS
Click here to add this to my saved trials
Saint Louis, Missouri 63141
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Sandy Springs, Georgia 30328
?
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Santa Monica, California 90404
?
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Tampa, Florida 33613
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Verona, New Jersey 07044
?
mi
from
Verona, NJ
Click here to add this to my saved trials
Warren, Michigan 48088
?
mi
from
Warren, MI
Click here to add this to my saved trials
West Palm Beach, Florida 33409
?
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Wilmington, North Carolina 28403
?
mi
from
Wilmington, NC
Click here to add this to my saved trials